» Articles » PMID: 27435598

Differential Effect of Mild and Severe Pulmonary Embolism on the Rat Lung Transcriptome

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2016 Jul 21
PMID 27435598
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pulmonary thromboembolism (PTE) is a common diagnosis and a leading cause of cardiovascular morbidity and mortality. A growing literature has associated PE with systemic inflammation, and global hyper-coagulability, which contribute to lung remodeling and clot recurrence. The source and mechanism of inflammation remains unstudied. In humans, inhibition of cholesterol synthesis with statins decreases biomarkers of inflammation. We test the differential effect of pulmonary vascular occlusion during mild and severe pulmonary embolism on the lung transcriptome.

Methods: Experimental PE was induced in adult male rats by injection of 25 micron polystyrene microspheres into the jugular vein. The effect of Mild PE, (2-h right ventricular systolic pressure [RVSP] normal, 18-h RVSP 44 mmHg) and Severe PE (2-h RVSP > 50 mmHg; 18-h RVSP 44 mmHg) on lungs was assessed by measuring transcriptome-wide changes in gene expression by DNA microarrays.

Results: Severe PE was associated with a large change in lung gene expression and in the expression of KEGG pathways and other gene functional annotation groups. Mild PE was also associated with a large number of significant changes in gene expression and in the expression of KEGG pathways and gene functional annotation groups, even after only 2 h of PE. Up-regulated pathways included increased adipocytokine, chemokine and cytokine signaling as well as cholesterol synthesis.

Conclusions: Mild PE without acute pulmonary hypertension (PH) increased lung gene expression of inflammatory pathways, including increased cholesterol synthesis. These data indicate that even mild persistent pulmonary vascular occlusion is capable of inciting an inflammatory response from the lung. These data imply the detrimental effect of unresolved pulmonary obstruction from PE.

Citing Articles

NUPR1 modulates pulmonary embolism progression via smooth muscle cells phenotypic transformation.

Wang S, Xu A, Chen M, Wu Y Heliyon. 2024; 10(21):e38918.

PMID: 39524834 PMC: 11550085. DOI: 10.1016/j.heliyon.2024.e38918.


Current status of ECMO for massive pulmonary embolism.

Davies M, Hart J Front Cardiovasc Med. 2024; 10:1298686.

PMID: 38179509 PMC: 10764581. DOI: 10.3389/fcvm.2023.1298686.


Pulmonary artery embolism: comprehensive transcriptomic analysis in understanding the pathogenic mechanisms of the disease.

Gromadzinski L, Paukszto L, Lepiarczyk E, Skowronska A, Lipka A, Makowczenko K BMC Genomics. 2023; 24(1):10.

PMID: 36624378 PMC: 9830730. DOI: 10.1186/s12864-023-09110-0.


Rodent models of pulmonary embolism and chronic thromboembolic pulmonary hypertension.

Karpov A, Vaulina D, Smirnov S, Moiseeva O, Galagudza M Heliyon. 2022; 8(3):e09014.

PMID: 35295664 PMC: 8919224. DOI: 10.1016/j.heliyon.2022.e09014.


Astragalin Inhibits Cigarette Smoke-Induced Pulmonary Thrombosis and Alveolar Inflammation and Disrupts PAR Activation and Oxidative Stress-Responsive MAPK-Signaling.

Kim Y, Kang M, Lee E, Kim D, Oh H, Kim S Int J Mol Sci. 2021; 22(7).

PMID: 33916310 PMC: 8036420. DOI: 10.3390/ijms22073692.


References
1.
Hoeper M, Mayer E, Simonneau G, Rubin L . Chronic thromboembolic pulmonary hypertension. Circulation. 2006; 113(16):2011-20. DOI: 10.1161/CIRCULATIONAHA.105.602565. View

2.
van Es J, Douma R, Kamphuisen P, Gerdes V, Verhamme P, Wells P . Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison of computed tomography and perfusion scintigraphy. J Thromb Haemost. 2013; 11(4):679-85. DOI: 10.1111/jth.12150. View

3.
Zhao G, Al-Mehdi A, Fisher A . Anoxia-reoxygenation versus ischemia in isolated rat lungs. Am J Physiol. 1998; 273(6):L1112-7. DOI: 10.1152/ajplung.1997.273.6.L1112. View

4.
Satoh M, Satoh A . 3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension. J Pharm Pharm Sci. 2009; 11(2):118s-130s. DOI: 10.18433/j34k5z. View

5.
Wei Z, Costa K, Al-Mehdi A, Dodia C, Muzykantov V, Fisher A . Simulated ischemia in flow-adapted endothelial cells leads to generation of reactive oxygen species and cell signaling. Circ Res. 1999; 85(8):682-9. DOI: 10.1161/01.res.85.8.682. View